Onderneming TherapeuticsMD Inc Nyse
Aandelen
US88338N1072
Farmaceutische producten
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
License
100,0
%
| 70 | 100,0 % | 1 | 100,0 % | -98,14% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 70 | 100,0 % | 1 | 100,0 % | -98,14% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marlan Walker
CEO | Chief Executive Officer | 50 | 01-06-13 |
Joseph Ziegler
DFI | Director of Finance/CFO | - | 17-08-23 |
Corporate Officer/Principal | - | 01-03-18 | |
General Counsel | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tommy Thompson
CHM | Chairman | 81 | 16-04-12 |
Cooper Collins
BRD | Director/Board Member | 45 | 28-02-12 |
Gail Naughton
BRD | Director/Board Member | 69 | 20-03-20 |
Justin Roberts
BRD | Director/Board Member | - | 23-08-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 11 532 443 | 11 313 203 ( 98,10 %) | 0 | 98,10 % |
Bedrijfsgegevens
TherapeuticsMD, Inc.
951 Yamato Road Suite 220
33431, Boca Raton
+561 961 1900
http://www.therapeuticsmd.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,48% | 69,91 mld. | |
+12,55% | 9,24 mld. | |
-13,75% | 5,05 mld. | |
+42,38% | 4,47 mld. | |
+4,51% | 3,92 mld. | |
-19,05% | 2,41 mld. | |
-28,72% | 2,23 mld. | |
+11,13% | 2,02 mld. | |
+6,53% | 1,66 mld. |